Erythrocyte–Cancer Hybrid Membrane-Camouflaged Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in Tumors
ACS Omega · 27.06.2023 · 8 (25) · 23056-23066
DOI: 10.1021/acsomega.3c02370 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 09.06.2023. Verfasst von Zhining Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ultrasound Department, First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Prussian blue (PB) nanoparticles have been widely used in photothermal therapy research due to the efficient photothermal conversion ability. In this study, PB was modified with a bionic coating using a hybrid membrane of red blood cell membranes and tumor cell membranes to prepare bionic photothermal nanoparticles (PB/RHM), which can further improve the blood circulation ability and tumor targeting of the nanoparticles to achieve efficient photothermal therapy for tumor treatment. In vitro formulation characterization showed that PB/RHM was a monodisperse spherical core–shell structured nanoparticle with a diameter of 207.2 nm and effectively retained the cell membrane proteins. The in vivo biological evaluation results showed that PB/RHM could effectively accumulate into the tumor tissue, inducing a rapid temperature increase in the tumor site to 50.9 °C within 10 min, inhibiting tumor growth efficiently with a tumor inhibition rate of 93.56% and with good therapeutic safety. In summary, this paper provided a hybrid film-modified Prussian blue nanoparticle with efficient photothermal anti-tumor capacity and safety.
Autor:innen und Institutionen
- Ultrasound Department, First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121001, China.
- College of Pharmacy, Shenzhen Technology University, Shenzhen 518118, China.
ORCID-Profile: Huichao Xie
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Liu, Z., Xie, H., & Wang, T. (2023). Erythrocyte–Cancer Hybrid Membrane-Camouflaged Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in Tumors. ACS Omega, 8(25), 23056-23066. https://doi.org/10.1021/acsomega.3c02370
Vancouver
Liu Z, Xie H, Wang T. Erythrocyte–Cancer Hybrid Membrane-Camouflaged Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in Tumors. ACS Omega. 2023;8(25):23056-23066. doi:10.1021/acsomega.3c02370
BibTeX
@article{Liu2023,
author = {Liu, Zhining and Xie, Huichao and Wang, Tianyi},
title = {Erythrocyte–Cancer Hybrid Membrane-Camouflaged Prussian Blue Nanoparticles with Enhanced Photothermal Therapy in Tumors},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {25},
pages = {23056--23066},
doi = {10.1021/acsomega.3c02370}
}
EUVIMED